Johns Hopkins Gets FDA OK to Test Blood Therapies for COVID-19 Patients
April 04, 2020
April 04, 2020
BALTIMORE, Maryland, April 4 [TNSscientificresearch] -- Johns Hopkins University's Bloomberg School of Public Health issued the following news release:
The U.S. Food and Drug Administration approved a clinical trial Friday that will allow Johns Hopkins University researchers to test a therapy for COVID-19 that uses plasma from recovering patients.
Arturo Casadevall, a Johns Hopkins infectious disease expert, proposed the use of convalescent plasma against COVID19 and as . . .
The U.S. Food and Drug Administration approved a clinical trial Friday that will allow Johns Hopkins University researchers to test a therapy for COVID-19 that uses plasma from recovering patients.
Arturo Casadevall, a Johns Hopkins infectious disease expert, proposed the use of convalescent plasma against COVID19 and as . . .